Bimekizumab versus Adalimumab in Plaque Psoriasis
- PMID: 34525293
- DOI: 10.1056/NEJMc2113092
Bimekizumab versus Adalimumab in Plaque Psoriasis
Comment in
-
Bimekizumab versus Adalimumab in Plaque Psoriasis. Reply.N Engl J Med. 2021 Sep 16;385(12):1150. doi: 10.1056/NEJMc2113092. N Engl J Med. 2021. PMID: 34525294 No abstract available.
Comment on
-
Bimekizumab versus Adalimumab in Plaque Psoriasis.N Engl J Med. 2021 Jul 8;385(2):130-141. doi: 10.1056/NEJMoa2102388. Epub 2021 Apr 23. N Engl J Med. 2021. PMID: 33891379 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical